reference/30482950

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30482950

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1756-8722
issueIdentifier	1
pageRange	43-
publicationName	Journal of Hematology & Oncology
startingPage	43
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7db02a20dfd8c547e594b57333c43ac8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d217484391d0ed45c7d92330f82566c5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f7804975b06d277fc403b824080701fa http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5d3914447cfc241a0aedc83f265c67ee
bibliographicCitation	Kim H, Park J, Park J, Yasmin F, Kim C, Oh SK, Chung I, Jun C. Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy. Journal of Hematology & Oncology. 2021 Mar 17;14(1):43. doi: 10.1186/s13045-021-01058-6.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa76dcf022bca2f366bf5dd6c9c9af55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_736bbbc04428965ef7cfaa61ffff668b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f88601c712103149edac65e8cd5ad3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0fd2941e46e5d66ec25a984b3f6d352 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_243fb5638d161805e3e2cde291f74506 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0edf2e71536c3af03258cf7dd66c8e54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1372-9277 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95c2178253178df5f25ad5189db27606
date	2021-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/s13045-021-01058-6 https://pubmed.ncbi.nlm.nih.gov/PMC7968273 https://pubmed.ncbi.nlm.nih.gov/33731208
isPartOf	https://portal.issn.org/resource/ISSN/1756-8722 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34231
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy
discusses	http://id.nlm.nih.gov/mesh/M0013781 http://id.nlm.nih.gov/mesh/M0590102 http://id.nlm.nih.gov/mesh/M0014239
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_003bca88048aa170ac5696f542758183 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21346

Total number of triples: 40.